CSTL CIK: 1447362

Castle Biosciences Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.0
FY22:
−41.7
FY23:
−5.63
FY24:
64.9
FY25:
64.3
Change from FY21 to FY25
millions USD
FY21:
−66.7
FY22:
−167
FY23:
−16.2
FY24:
−50.1
FY25:
−60.4
Change from FY21 to FY25
millions USD
FY21:
5.42
FY22:
1.52
FY23:
−2.30
FY24:
6.14
FY25:
−6.96
millions USD
FY21:
−80.2
FY22:
−207
FY23:
−24.1
FY24:
20.9
FY25:
−2.98
(positive)
Change from FY21 to FY25
millions USD
FY21:
−22.5
FY22:
−47.3
FY23:
−19.2
FY24:
36.5
FY25:
28.3

All amounts in millions USD Data source:SEC EDGAR